Últimos ensayos

EudraCT Number: 2007-006754-26

Sponsor Protocol Number: PLA/01/06

Start Date: 2006-11-28

Sponsor Name: MASTELLI SRL

Full Title: DIABETIC FOOT ULCERS AND POLYDEOXYRIBONUCLEOTIDE (PLACENTEX INTEGRO MASTELLI) AS A TREATMENT FOR WOUND HEALING

Medical condition: Diabetic foot ulcer

Disease:	Version	SOC Term	Classification Code	Term	Level
	9.1		10056340	Diabetic ulcer	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: IT (Completed) SI (Completed)

Trial results: (No results available)

EudraCT Number: 2006-003876-37

Sponsor Protocol Number: CS866CM-B-E301

Start Date: 2006-11-28

Sponsor Name: DAIICHI SANKYO EUROPE GmbH

Full Title: Efficacy and Safety of Hydrochlorothiazide Used as Add-on Therapy in Moderately to Severely Hypertensive Patients not Adequately Controlled by Olmesartan Medoxomil 40 mg Monotherapy

Medical condition: Essential hypertension

Disease:	Version	SOC Term	Classification Code	Term	Level
	8.1		10015488	Essential hypertension	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed) CZ (Completed) FR (Ongoing) ES (Completed)

Trial results: View results

EudraCT Number: 2006-002565-39

Sponsor Protocol Number: 2006015

Start Date: 2006-11-27

Sponsor Name: South Tees Acute Hospitals NHS Trust

Full Title: Effects of the Modification of the Daily Flow Rate with a Constant Daily Dose on Patient's Reported Analgesia in Intathecal Therapy

Medical condition: Chronic Pain.

Disease:	Version	SOC Term	Classification Code	Term	Level
	8.1		10049475	Chronic pain	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (Completed)

Trial results: View results

EudraCT Number: 2006-004979-35

Sponsor Protocol Number: 05-FOR-01 SE

Start Date: 2006-11-27

Sponsor Name: Andi - Ventis

Full Title: A RANDOMISED, FOUR WAY CROSS-OVER STUDY TO ASSESS BRONCHODILATION, SAFETY AND TOLERABILITY OF NEW GENERIC DRY POWDER FORMOTEROL FORMULATIONS GIVEN AS CUMULATIVE DOSES FROM A NOVEL DRY POWDER INHALE...

Medical condition: reversible mild asthma

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults

Gender: Male, Female

Trial protocol: HU (Completed)

Trial results: (No results available)

EudraCT Number: 2006-003870-88

Sponsor Protocol Number: RPCE06G2013

Start Date: 2006-11-27

Sponsor Name: UCB Pharma S.A.

Full Title: A Phase IIIb, multi-center, double-blind, placebo-controlled, randomized trial to examine the corticosteroid-sparing effect of certolizumab pegol in patients with moderate to severe Crohn's disease...

Medical condition: In the present study, the corticosteroid-sparing effect of certolizumab pegol will be assessed in patients with moderate to severe Crohn’s disease who have received initial acute corticosteroid the...

Disease:	Version	SOC Term	Classification Code	Term	Level
	8.1		10011401	Crohn's disease	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed)

Trial results: View results

EudraCT Number: 2006-003699-36

Sponsor Protocol Number: 20050154

Start Date: 2006-11-27

Sponsor Name: Amgen Inc.

Full Title: A Phase 2, Randomized, Double Blind, Placebo- Controlled Dose and Schedule Finding Trial to Evaluate the Safety and Efficacy of AMG 531 for Treatment of Chemotherapy- Induced Thrombocytopenia in Su...

Medical condition: Secondary prophylaxis for the treatment of chemotherapy induced thrombocytopenia (CIT) in subjects with Non-Small Cell Lung Cancer (NSCLC) receiving myelosuppressive chemotherapy.

Disease:	Version	SOC Term	Classification Code	Term	Level
	8.1		10023780	Large cell lung cancer stage IV	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: IE (Completed) PT (Completed) AT (Prematurely Ended) HU (Completed) DE (Completed) IT (Completed)

Trial results: View results

EudraCT Number: 2006-000813-39

Sponsor Protocol Number: H7T-MC-TABL

Start Date: 2006-11-27

Sponsor Name: Eli Lilly and Company

Full Title: Prasugrel in comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation (PRINCIPLE) - TIMI 44

Medical condition: subjects undergoing elective cardiac catheterization with planned percutaneous coronary intervention (PCI) with coronary stenting.

Disease:	Version	SOC Term	Classification Code	Term	Level
	8.1		10023031	Ischemia coronary artery origin	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: FR (Ongoing) DE (Completed)

Trial results: View results

EudraCT Number: 2006-002216-10

Sponsor Protocol Number: 2006012

Start Date: 2006-11-27

Sponsor Name: Procter & Gamble Pharmaceuticals

Full Title: A Multicenter, Double-blind, Randomized, Parallel, Placebo-controlled Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of 2 Oral Doses, 25 mg Twice Daily and 100 mg Twice Daily, of PG 7...

Medical condition: Rheumatoid Arthritis

Disease:	Version	SOC Term	Classification Code	Term	Level
	8.1		10039073	Rheumatoid arthritis	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: CZ (Completed) HU (Completed) NL (Completed) GB (Completed)

Trial results: (No results available)

EudraCT Number: 2005-004009-26

Sponsor Protocol Number: E7389-G000-301

Start Date: 2006-11-27

Sponsor Name: Eisai Limited

Full Title: A Phase III Open Label, Randomized Two-Parallel-Arm Multicenter Study of E7389 versus Capecitabine in Patients with Locally Advanced or Metastatic Breast Cancer Previously Treated with Anthracyclin...

Medical condition: Locally advanced or metastatic breast cancer

Disease:	Version	SOC Term	Classification Code	Term	Level
	8.1		10055113		PT

Population Age: Adults, Elderly

Gender: Female

Trial protocol: HU (Completed) BE (Completed) CZ (Completed) LT (Completed) DE (Completed) FR (Completed) IT (Prematurely Ended) GR (Completed) BG (Completed) ES (Completed)

Trial results: View results

EudraCT Number: 2006-001434-41

Sponsor Protocol Number: NH20052

Start Date: 2006-11-27

Sponsor Name: F. Hoffmann-La Roche Ltd

Full Title: An open-label, randomized, multicenter, parallel group study to demonstrate correction of anemia using once every four week subcutaneous injections of RO0503821 in patients with chronic kidney dise...

Medical condition: Chronic renal anemia

Disease:	Version	SOC Term	Classification Code	Term	Level
	8.1		10058124	Nephrogenic anemia	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed) FR (Completed) SE (Prematurely Ended) GR (Completed) IT (Completed) BE (Completed) HU (Completed) ES (Completed)

Trial results: View results

Últimos ensayos

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas